ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 717.50
+28.00 (4.06%)
Jan 8, 2026, 4:59 PM CET
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 12.49 billion as of January 8, 2026. Its market cap has increased by 44.25% in one year.
Market Cap
12.49B
Enterprise Value
12.15B
Revenue
495.57M
Ranking
n/a
PE Ratio
66.99
Stock Price
717.50
Market Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 12.49B, an increase of 3,234.26%. That is a compound annual growth rate of 20.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 12.49B | 4.36% |
| Dec 30, 2025 | 11.96B | 41.40% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.63T |
| Genmab | 132.44B |
| Coloplast | 127.06B |
| ALK-Abelló | 50.83B |
| Demant | 47.25B |
| H. Lundbeck | 42.88B |
| Zealand Pharma | 29.89B |
| Ambu A/S | 23.38B |